Precision Medicine for High-Risk Gene Fusions in Pediatric AML: a focus on KMT2A, NUP98, and GLIS2 Rearrangements
Blood. 2025 Jan 14:blood.2024026598. doi: 10.1182/blood.2024026598. Online ahead of print. ABSTRACT Robust genetic characterization of paediatric AML has demonstrated that fusion oncogenes are highly prevalent …